- Cinemark Holdings (NYSE: CNK) surpassed Q1 2026 revenue estimates, reporting $643.1 million, an 18.9% increase year-over-year.
- The company significantly improved its earnings per share (EPS) to -$0.06, a notable recovery from a $0.32 loss in the prior year.
- Despite strong revenue performance, Cinemark Holdings faces potential liquidity concerns with a current ratio of 0.41, while its price-to-sales ratio stands at 1.05.
Cinemark Holdings (NYSE: CNK) is a major company in the movie theater business, operating cinemas across the Americas. The company makes money mainly from selling movie tickets and concessions like popcorn and drinks. Its current debt-to-equity ratio, a key measure of financial leverage, stands at 9.34.
On May 1, 2026, Cinemark Holdings announced its first-quarter financial results. The company reported total revenues of $643.1 million, beating the market’s consensus estimate of $632.74 million. This revenue figure also represents a strong 18.9% increase from the $540.7 million earned in the same period one year prior, highlighting positive revenue growth in the cinema chain sector.
The company’s earnings per share (EPS) came in at -$0.06, which was an improvement over the estimated loss of $0.09 per share. However, as highlighted by Zacks, this result was slightly wider than their consensus estimate of a $0.05 per share loss, showing how analyst expectations can differ in quarterly earnings reports.
Despite the small net loss, the EPS of -$0.06 is a significant improvement from the $0.32 per share loss reported a year ago. Over the last four quarters, Cinemark Holdings has successfully beaten revenue estimates three times, though it has not consistently surpassed consensus earnings estimates in that same timeframe, offering mixed signals for investment insights.
The company’s current ratio is 0.41. This ratio measures a company’s ability to pay its short-term bills, and a value under 1 can indicate potential liquidity challenges. Meanwhile, its price-to-sales ratio for the last twelve months is 1.05, valuing each dollar of sales at $1.05 in its stock price, providing a key valuation metric for stock analysis.
